$vnda
Vanda Pharmaceuticals sees a surge in social media engagement, driven by discussions around FDA decisions and biotech stock performance. The company is actively awaiting key regulatory approvals for its CNS disorder treatments.
About $vnda
Vanda Pharmaceuticals is a biopharmaceutical company focused on developing treatments for central nervous system disorders.
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Month: [-------] -44%
[--] Months: [---------] +363%
[--] Year: [---------] -45%
1-Year High: [-------] on 2025-12-31
1-Year Low: [--] on 2025-09-15
Engagements by network (24h): X: [------] Reddit: [--] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-19
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): X: [--] Reddit: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $vnda in the last [--] hours which is up 7.80% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-11-19
1-Year Low: [--] on 2025-09-14
The most influential creators that mention $vnda in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [------] |
| @MiriamF24887120 | [--] | [--] | [--] | [---] |
| @fastmoneysource | [--] | [---] | [--] | [--] |
| @ElMonoGran42994 | [--] | [---] | [--] | [--] |
| @DoodadDoctor | [--] | [--] | [--] | [--] |
| @byul_finance | [--] | [---] | [--] | [--] |
| @Biotechmaster12 | [--] | [-----] | [--] | [--] |
| @Beverly97739735 | [--] | [---] | [--] | [--] |
| @FormalyTwilter | [--] | [---] | [--] | [--] |
| @omrfsef | [--] | [--] | [--] | [--] |
Sentiment: 64%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 64%
Daily Average: 81%
[--] Month: 75% -3%
[--] Months: 75% -25%
[--] Year: 75% -25%
1-Year High: 100% on 2025-02-17
1-Year Low: 12% on 2025-11-11
Most Supportive Themes:
- FDA Decisions: (50%) Vanda Pharmaceuticals is awaiting FDA decisions on its treatments, which are crucial for future drug approvals and market entry.
- Biotech Stock Performance: (50%) Vanda Pharmaceuticals is mentioned in the context of broader biotech stock movements, indicating investor interest in the sector.
Most Critical Themes:
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing